Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Lifestyle-related disease is on the rise in South Africa, including high blood pressure. An ingenious partnership involving Oxford University is putting the nation’s extensive mobile phone network to work in beating the disease.

Image courtesy of Shutterstock

Out in the townships of South Africa’s Western Cape, unemployment can run at 44 per cent. Entire households may depend on a single old age pension for food. Gang violence leaves people wary of being robbed on the way to a clinic appointment.

With life so chaotic and stressful for many, remembering to take your hypertension medication may seem like a small side issue. But while HIV and TB are epidemic in many communities, there is also a creeping rise in chronic lifestyle diseases. These include hypertension, now the leading cause of death and disability worldwide. According to the South African Medical Research Council, 6.2 million people in a population of 52 million have high blood pressure and 3.2 million have unacceptably high levels, heightening the risk of heart attacks and strokes.

Read more

Similar stories

Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age

A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.

Drug could help diabetic hearts recover after heart attack - Oxford research

Researchers at the University of Oxford have identified a drug that could ultimately help improve heart function in people with diabetes who have heart attacks.

Largest ever global study of tuberculosis identifies genetic causes of drug resistance

Using cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis (TB) drug treatments.

Researchers set out steps to address mental health effects of the pandemic on young people

Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.

Anti-cancer drug derived from fungus shows promise in clinical trials

A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.

No benefit of convalescent plasma for critically ill COVID-19 patients

A large study of over 2000 COVID-19 patients has found that giving critically ill patients blood plasma from recovered COVID-19 patients did not significantly reduce deaths, or the need for intensive care support such as being put on a ventilator machine.